Clinical Trials Logo

Filter by:
NCT ID: NCT00208078 Terminated - Cystic Fibrosis Clinical Trials

Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.

Start date: May 2005
Phase: Phase 4
Study type: Interventional

There is no randomised controlled trials to determine the clinical effects of long term Non-Invasive Ventilation in Cystic Fibrosis patients.

NCT ID: NCT00207831 Terminated - Rectal Cancer Clinical Trials

Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma

UFT RT Phase 3
Start date: July 2004
Phase: Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as 5-fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing and also as a radiosensibilisant. Radiation therapy uses high-energy x-rays to kill tumor cells. 5-fluorouracil may make tumor cells more sensitive to radiation therapy. Oral 5-fluorouracil is more convenient for ambulatory patients. Giving UFT (Tegafur and Uracil) with radiation therapy before surgery may shrink the tumor so it can be removed. PURPOSE: This phase III trial is studying how well giving UFT with radiation therapy works in treating patients who are undergoing surgery for operable rectal cancer.

NCT ID: NCT00206089 Terminated - Thromboembolism Clinical Trials

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

EXTEND
Start date: September 2005
Phase: Phase 3
Study type: Interventional

This study is being carried out to study the efficacy and safety of treatment with melagatran injection followed by ximelagatran tablets in preventing blood clots, compared with enoxaparin for a period of 5-6 weeks. A separate visit, independent from the study will be done approximately 6 months after the surgery.

NCT ID: NCT00202670 Terminated - Diabetes Mellitus Clinical Trials

Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients

Start date: January 2004
Phase: Phase 4
Study type: Observational

The aim of this study is to determine in high risk diabetics if the positive predictive value of stress echocardiography is superior to the positive predictive value of stress scintigraphy in the diagnosis of coronary stenosis > 50%.

NCT ID: NCT00202540 Terminated - Clinical trials for Mild Cognitive Impairment

Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients

Start date: June 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI

NCT ID: NCT00200694 Terminated - Heavy Proteinuria Clinical Trials

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

Start date: March 2005
Phase: Phase 4
Study type: Interventional

Determine the best strategy for proteinuria lowering in patients with proteinuria > 1 g/day receiving ACEI and ARB combination: either increase of ACEI and ARB dosage or increase of diuretic dosage.

NCT ID: NCT00200668 Terminated - Multiple Myeloma Clinical Trials

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

Start date: March 2005
Phase: N/A
Study type: Interventional

Comparison between FDG-PET and MRI for the assessment of response to intensive chemotherapy in multiple myeloma patients.

NCT ID: NCT00200590 Terminated - Pain Clinical Trials

Analgesic Strategies in Newborns Receiving Prostaglandin Therapy

Start date: December 2003
Phase: N/A
Study type: Interventional

This is a randomised trial comparing the efficacy of 3 different analgesic strategies in newborns on prostaglandin for ductus dependent congenital heart disease.

NCT ID: NCT00199238 Terminated - URTICARIA Clinical Trials

Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria

Start date: October 28, 2002
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of rupatadine for the treatment of CIU symptoms.To assess the clinical efficacy of a dose ranging of rupatadine fumarate (5mg, 10mg, and 20 mg) compared with placebo for relief of CIU symptoms.

NCT ID: NCT00195897 Terminated - Lymphoma Clinical Trials

Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)

Start date: January 2006
Phase: N/A
Study type: Observational

Anthracycline-based chemotherapy is a key point of the treatment of patients with Hodgkin's and non-Hodgkin's lymphomas. However, cumulative doses are limited by cardiotoxicity, resulting in a marked left ventricular function impairment that may lead to heart failure. The standard clinical approach to monitoring for anthracycline cardiotoxicity is based on cardiac function monitoring using echocardiography or radionuclide angiography. The aim of this study is to evaluate the usefulness of biochemical markers of cardiac injury (troponin and NT-proBNP) and structural changes on cardiac MR in predicting anthracycline cardiotoxicity.